These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
495 related items for PubMed ID: 12374688
21. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F. Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646 [Abstract] [Full Text] [Related]
22. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma]. Zhao J, Hu J, Cai J. Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769 [Abstract] [Full Text] [Related]
23. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Werther K, Christensen IJ, Nielsen HJ, Danish RANX05 Colorectal Cancer Study Group. Br J Cancer; 2002 Feb 01; 86(3):417-23. PubMed ID: 11875709 [Abstract] [Full Text] [Related]
24. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy]. Dong L, Chang XH, Ye X, Zhu LR, Zhao Y, Tian L, Cheng HY, Li XP, Zhang H, Liao QP, Fu TY, Cheng YX, Cui H. Zhonghua Fu Chan Ke Za Zhi; 2008 Dec 01; 43(12):931-6. PubMed ID: 19134334 [Abstract] [Full Text] [Related]
25. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy. Hazelton D, Nicosia RF, Nicosia SV. Clin Cancer Res; 1999 Apr 01; 5(4):823-9. PubMed ID: 10213218 [Abstract] [Full Text] [Related]
27. Do preoperative serum vascular endothelial growth factor and migration-inhibitory factor predict the nature of the adnexal masses? A prospective-controlled trial. Yildirim N, Dikmen Y, Terek MC, Akman L, Gunel NS, Aktan C, Zekioglu O, Gunduz C. J Obstet Gynaecol; 2016 May 01; 36(4):533-7. PubMed ID: 26758243 [Abstract] [Full Text] [Related]
37. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors. Holzer G, Obermair A, Koschat M, Preyer O, Kotz R, Trieb K. Med Pediatr Oncol; 2001 Jun 01; 36(6):601-4. PubMed ID: 11344490 [Abstract] [Full Text] [Related]
38. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480. George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ, Kantoff PW, Cancer and Leukemia Group B 9480. Clin Cancer Res; 2001 Jul 01; 7(7):1932-6. PubMed ID: 11448906 [Abstract] [Full Text] [Related]
39. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. Jacobsen J, Rasmuson T, Grankvist K, Ljungberg B. J Urol; 2000 Jan 01; 163(1):343-7. PubMed ID: 10604387 [Abstract] [Full Text] [Related]
40. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation. Tuttle RM, Fleisher M, Francis GL, Robbins RJ. J Clin Endocrinol Metab; 2002 Apr 01; 87(4):1737-42. PubMed ID: 11932308 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]